GlassScriptPhysician profile
Heather Burchett
NPI 1528375672
$4,324.19
in general payments reported to CMS, 2019-2025
18 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what 82% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $484 · 2022: $276 · 2023: $1,324 · 2024: $1,121 · 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,563.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,590.42 | 2021-2025 | |
| Axsome Therapeutics, INC. | $614.64 | 2023-2025 | Auvelity |
| Lundbeck LLC | $416.35 | 2021-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $294.38 | 2022-2024 | Caplyta |
| Ironshore Pharmaceuticals INC. | $252.35 | 2021-2023 | Jornay Pm |
| Corium, LLC | $235.99 | 2023-2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $154.06 | 2021-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $152.41 | 2021-2024 | Spravato |
| Supernus Pharmaceuticals, INC. | $136.21 | 2021-2022 | |
| United Therapeutics Corporation | $123.10 | 2023 | |
| Sunovion Pharmaceuticals INC. | $105.39 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $58.22 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.45 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $48.82 | 2023 | Quviviq |
| Alkermes, INC. | $36.65 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $20.96 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.62 | 2022 | |
| Boston Scientific Corporation | $14.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Burchett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.